UCB
VRTX icon

United Community Bank’s Vertex Pharmaceuticals VRTX Stock Holding History

United Community Bank’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.25K Sell
14
-21
-60% -$9.79K ﹤0.01% 482
2025
Q4 		$15.9K Sell
35
-27
-44% -$11.6K 0.01% 397
2025
Q3 		$24.3K Buy
62
+34
+121% +$14.2K 0.01% 389
2025
Q2 		$12.5K Buy
28
+7
+33% +$3.23K ﹤0.01% 406
2025
Q1 		$10.2K Buy
+21
New +$9.79K ﹤0.01% 411

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

United Community Bank's VRTX Position: Q1 2026 in Review

United Community Bank reduced its Vertex Pharmaceuticals (VRTX) stake by 60% in Q1 2026, selling an estimated $9.79K and leaving 14 shares worth $6.25K. The position accounts for ﹤0.01% of the portfolio, ranked #482.

United Community Bank first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $24.3K in Q3 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • United Community Bank held 14 shares of Vertex Pharmaceuticals worth $6.25K as of Q1 2026.
  • United Community Bank sold 21 Vertex Pharmaceuticals shares in Q1 2026, an estimated $9.79K.
  • Vertex Pharmaceuticals made up ﹤0.01% of United Community Bank's portfolio in Q1 2026, its #482 holding.
  • United Community Bank first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • United Community Bank's Vertex Pharmaceuticals position peaked at $24.3K in Q3 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on United Community Bank's 13F filing for Q1 2026, filed 24 Apr 2026.